You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 21, 2024

MIDODRINE HYDROCHLORIDE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Midodrine Hydrochloride, and what generic alternatives are available?

Midodrine Hydrochloride is a drug marketed by Alembic, Apotex, Aurobindo Pharma Ltd, Chartwell Rx, Endo Operations, Impax Pharms, Mankind Pharma, Mylan Pharms Inc, Novugen, Rubicon, Thinq Pharm-cro Pvt, Xiromed, and Zydus Lifesciences. and is included in thirteen NDAs.

The generic ingredient in MIDODRINE HYDROCHLORIDE is midodrine hydrochloride. There are thirteen drug master file entries for this compound. Twenty-eight suppliers are listed for this compound. Additional details are available on the midodrine hydrochloride profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Midodrine Hydrochloride

A generic version of MIDODRINE HYDROCHLORIDE was approved as midodrine hydrochloride by MYLAN PHARMS INC on September 10th, 2003.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for MIDODRINE HYDROCHLORIDE?
  • What are the global sales for MIDODRINE HYDROCHLORIDE?
  • What is Average Wholesale Price for MIDODRINE HYDROCHLORIDE?
Drug patent expirations by year for MIDODRINE HYDROCHLORIDE
Recent Clinical Trials for MIDODRINE HYDROCHLORIDE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Noha MansourPhase 4
Henan Provincial People's HospitalN/A
First Affiliated Hospital Xi'an Jiaotong UniversityN/A

See all MIDODRINE HYDROCHLORIDE clinical trials

Pharmacology for MIDODRINE HYDROCHLORIDE
Medical Subject Heading (MeSH) Categories for MIDODRINE HYDROCHLORIDE

US Patents and Regulatory Information for MIDODRINE HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Thinq Pharm-cro Pvt MIDODRINE HYDROCHLORIDE midodrine hydrochloride TABLET;ORAL 207613-002 Nov 2, 2018 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Rubicon MIDODRINE HYDROCHLORIDE midodrine hydrochloride TABLET;ORAL 212543-001 Aug 19, 2019 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Thinq Pharm-cro Pvt MIDODRINE HYDROCHLORIDE midodrine hydrochloride TABLET;ORAL 207613-003 Nov 2, 2018 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Rubicon MIDODRINE HYDROCHLORIDE midodrine hydrochloride TABLET;ORAL 212543-002 Aug 19, 2019 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Alembic MIDODRINE HYDROCHLORIDE midodrine hydrochloride TABLET;ORAL 214734-001 Jan 21, 2021 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Impax Pharms MIDODRINE HYDROCHLORIDE midodrine hydrochloride TABLET;ORAL 076449-003 Dec 16, 2005 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Mylan Pharms Inc MIDODRINE HYDROCHLORIDE midodrine hydrochloride TABLET;ORAL 076577-003 Sep 10, 2003 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.